Original Research J Clin Psychiatry October 2022

The Economic Burden of Schizophrenia in the United States

JCP 2022;83(6):10.4088/JCP.22m14458

Full Article Read the complete peer-reviewed article in J Clin Psychiatry. JCP 2022;83(6):10.4088/JCP.22m14458 Clinical Summary For patients with schizophrenia, the clinical burden extends well beyond symptoms and hospital use to unemployment, caregiving demands, premature mortality, homelessness, and involvement with social and legal systems. This analysis shows that in 2019 the largest costs were outside routine medical care, underscoring why psychiatrists should view effective management as important not only for symptom control but also for reducing family and societal burden. FAQ How much did schizophrenia cost the United States in 2019? 11 questions
Key Takeaways Indirect costs dominated the 2019 burden at $251.9 billion, or 73.4% of the total, indicating that schizophrenia’s economic impact extends far beyond medical spending and should be considered in care planning and policy discussions. 6 takeaways Clinical Guide How should clinicians and health systems prioritize schizophrenia management targets based on the main contributors to economic burden? 6 steps
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe